HYLENEX Recombinant - Hyaluronidase Recombinant Human
Navigation: NDC > Supplier starting with: B > BAXTER HEALTHCARE CORPORATION| Field | Value |
|---|---|
| NDC Code: | 60977-319 |
| Proprietary Name: | HYLENEX Recombinant |
| Suffix: | |
| Non-Proprietary Name: | Hyaluronidase Recombinant Human |
| Dosage Form: | INJECTION, SOLUTION |
| Method: | SUBCUTANEOUS |
| Original Marketing Date: | 02-12-2005 |
| Category Name: | NDA |
| Application Number: | NDA021859 |
| Labeler: | BAXTER HEALTHCARE CORPORATION |
| Substance Name: | HYALURONIDASE RECOMBINANT HUMAN |
| Active Numerator Strength: | 150 |
| Active Ingredient Unit: | [USP'U]/mL |
| Pharm Classes: | Endoglycosidase [EPC],Glycoside Hydrolases [Chemical/Ingredient] |
| DEA Schedule: |